HCA
NVO

Harbour Capital Advisors’s Novo Nordisk NVO Stock Holding History

Harbour Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,300
Closed -$370K – 298
2025
Q2 		$370K Sell
5,300
-40
-0.7% -$2.72K 0.08% 211
2025
Q1 		$358K Sell
5,340
-2,309
-30% -$191K 0.09% 202
2024
Q4 		$670K Sell
7,649
-1,020
-12% -$110K 0.15% 135
2024
Q3 		$1.01M Sell
8,669
-305
-3% -$40.7K 0.23% 97
2024
Q2 		$1.3M Buy
8,974
+710
+9% +$94.1K 0.31% 73
2024
Q1 		$1.05M Buy
8,264
+100
+1% +$11.9K 0.26% 86
2023
Q4 		$846K Buy
8,164
+35
+0.4% +$3.46K 0.23% 92
2023
Q3 		$739K Buy
8,129
+3,681
+83% +$324K 0.22% 103
2023
Q2 		$355K Buy
+4,448
New +$363K 0.1% 177
2017
Q2 		– Sell
-1,030
Closed -$17.7K – 478
2017
Q1 		$17.7K Buy
+1,030
New +$17.9K 0.01% 504
2015
Q4 		– Sell
-10,330
Closed -$280K – 233
2015
Q3 		$280K Sell
10,330
-400
-4% -$11.3K 0.2% 150
2015
Q2 		$294K Buy
+10,730
New +$302K 0.18% 154

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Harbour Capital Advisors's NVO Position: Q3 2025 in Review

Harbour Capital Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,300 shares — an estimated $370K sold.

Harbour Capital Advisors first reported a position in NVO in Q2 2015 and held it in 12 quarters. The position peaked at $1.3M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Harbour Capital Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Harbour Capital Advisors sold 5,300 Novo Nordisk shares in Q3 2025, an estimated $370K.
  • Harbour Capital Advisors first reported a position in Novo Nordisk in Q2 2015 and held it in 12 quarters.
  • Harbour Capital Advisors's Novo Nordisk position peaked at $1.3M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Harbour Capital Advisors's 13F filing for Q3 2025, filed 9 Oct 2025.